Precision Billing for a Specialty Defined by Detail

Blood transfusions and infusion therapy are among the highest-value services in hematology, and they come with detailed billing requirements that demand precision. Transfusion administration codes, the correct reporting of blood products, concurrent infusion sequencing, and drug administration coding all need to be handled correctly to ensure full reimbursement. Medisure ensures that every transfusion and infusion encounter is coded based on exactly what was administered, in what order, and for how long, capturing the complete value of every treatment visit your practice provides.

Hematology practices that perform bone marrow biopsies, aspirations, and related diagnostic procedures are working with high-value CPT codes that require detailed documentation to support reimbursement. The distinction between biopsy and aspiration coding, the correct reporting of bilateral procedures, and the documentation of medical necessity for these invasive diagnostic studies all affect whether and how much these claims pay. At Medisure, we review every procedure note carefully and apply the most accurate codes based on what was performed, ensuring that your procedural revenue is protected on every claim.

Many hematology treatments, particularly for patients on specialty biologics, clotting factor therapies, and erythropoiesis-stimulating agents, require prior authorization from payers before treatment can be administered. Missing or expired authorizations on these high-cost therapies result in significant revenue loss. Medisure manages the prior authorization process alongside your clinical team, tracking every active approval, following up on renewals, and flagging potential issues before they affect treatment or billing. This proactive management protects your highest-value claims from one of the most common and avoidable causes of denial in hematology.

Hematology claims are frequently denied due to medical necessity disputes, prior authorization failures, and drug coverage issues for high-cost specialty medications and blood products. At Medisure, we address these risks on the front end through thorough pre-submission audits and on the back end through fast, detailed appeals when denials do occur. Our team knows the specific denial patterns in hematology and responds to every rejected claim with the clinical and administrative documentation needed to overturn it.

Hematology practices generate revenue across a mix of office-based management, diagnostic procedures, and infusion services, and understanding your financial performance requires reporting that covers all of it. At Medisure, we provide comprehensive monthly revenue cycle reports that break down collections by service category, track infusion and transfusion revenue separately, and monitor AR aging across every payer. We pursue every outstanding balance with consistency and keep your practice informed about its financial performance so you always know exactly where your revenue stands.